Isofol Medical
ISOFOL | ST
Overview
Corporate Details
- ISIN(s):
- SE0009581051
- LEI:
- 549300MCXYAHG7VBHX75
- Country:
- Sweden
- Address:
- C/O Biotech Center, Arvid Wallgrens, 413 46 Göteborg
- Website:
- https://isofolmedical.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Isofol Medical AB (publ), founded in 2008, is a biotech company that is developing a new drug candidate for the treatment of advanced colorectal cancer. Colorectal cancer (CRC) is the third most common form of cancer worldwide and there is a very high need for more effective drugs to treat this disease. Vision: “Isofol will help extend life and improve the quality of life for cancer patients” Arfolitixorin is being developed and commercialized through a global licensing agreement with Merck & Cie in Germany. The licensing agreement also grants Isofol access to the unique patented manufacturing process for arfolitixorin.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Nytt antal aktier och röster i Isofol
|
Swedish | 60.6 KB | |
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
New number of shares and votes in Isofol
|
English | 61.3 KB | |
| 2025-07-04 18:00 |
Regulatory News Service
Isofol's rights issue fully subscribed – exercises overallotment for Japanese p…
|
English | 128.5 KB | |
| 2025-07-04 18:00 |
Share Issue/Capital Change
Isofols företrädesemission övertecknad – utnyttjar övertilldelning till japansk…
|
Swedish | 127.3 KB | |
| 2025-06-17 08:40 |
Prospectus
Isofol offentliggör prospekt i samband med bolagets företrädesemission
|
Swedish | 98.7 KB | |
| 2025-06-17 08:40 |
Prospectus
Isofol publishes prospectus in connection with the company’s rights issue
|
English | 119.6 KB | |
| 2025-06-11 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Bulletin from extraordinary general meeting in Isofol Medical AB (publ) held on…
|
English | 94.5 KB | |
| 2025-06-11 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från extra bolagsstämma i Isofol Medical AB (publ) den 11 juni 2025
|
Swedish | 74.5 KB | |
| 2025-06-05 08:30 |
Share Issue/Capital Change
Isofol offentliggör slutliga villkor i företrädesemission samt för en potentiel…
|
Swedish | 142.5 KB | |
| 2025-06-05 08:30 |
Share Issue/Capital Change
Isofol announces final terms of the rights issue and the potential overallotmen…
|
English | 167.4 KB | |
| 2025-05-21 16:40 |
Declaration of Voting Results & Voting Rights Announcements
Bulletin from annual general meeting in Isofol Medical AB (publ) held on May 21…
|
English | 95.5 KB | |
| 2025-05-21 16:40 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från årsstämma i Isofol Medical AB (publ) den 21 maj 2025
|
Swedish | 90.1 KB | |
| 2025-05-21 08:00 |
Interim Report
|
Swedish | 725.3 KB | |
| 2025-05-21 08:00 |
Regulatory News Service
|
English | 722.9 KB | |
| 2025-05-12 08:45 |
Pre-Annual General Meeting Information
Kallelse till extra bolagsstämma den 11 juni 2025 i Isofol Medical AB (publ)
|
Swedish | 135.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-11 | Magnus Hurst | Other | Buy | 35,000 | 24,150.00 SEK |
| 2022-09-12 | AB Windar | Other | Buy | 500,000 | 305,000.00 SEK |
| 2021-12-09 | Tony Gustavsson | Other | Sell | 58,767 | 858.00 SEK |
| 2021-12-09 | Tony Gustavsson | Other | Sell | 58,767 | 152.79 SEK |
| 2021-06-14 | HealthCom GmbH | Other | Buy | 233,336 | 1,493,350.40 SEK |
| 2021-06-10 | Gustaf Albèrt | Other | Other | 15,153 | 96,979.20 SEK |
| 2020-11-23 | Tony Gustavsson | Other | Buy | 58,767 | 43,487.58 SEK |
| 2020-11-23 | Tony Gustavsson | Other | Buy | 58,767 | 29,971.17 SEK |
| 2020-11-16 | Sven Eriksson | Other | Sell | 58,767 | 43,487.58 SEK |
| 2020-11-16 | Sven Eriksson | Other | Sell | 58,767 | 29,971.17 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Ascelia Pharma | Sweden | ACE | |
|
Atrys Health S.A. | Spain | ATRY | |
|
AUKETT SWANKE GROUP PLC | United Kingdom | AUK | |
|
Azorean - Aquatic Technologies S.A. | Portugal | MLAAT | |
|
Bachem Holding AG | Switzerland | BANB | |
|
Bavarian Nordic | Denmark | BAVA | |
|
BB Biotech AG | Switzerland | BION | |
|
BEEKS FINANCIAL CLOUD GROUP PLC | United Kingdom | BKS | |
|
BenevolentAI | United Kingdom | BAI | |
|
BerGenBio | Norway | BGBIO |